← Open Payments lookup

ROBERT BOHNERT: Open Payments

NPI 1174293559 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,606 in 80 payments from 18 companies in 2025. Trend: 2023 $590 · 2024 $830 · 2025 $1,606

Food & beverage: $1,606
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.18$351
ABBVIE INC.17$323
PFIZER INC.12$191
Regeneron Healthcare Solutions, Inc.3$108
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$105
GENZYME CORPORATION2$95
Madrigal Pharmaceuticals4$74
Gilead Sciences, Inc.2$43
Aimmune Therapeutics, Inc.2$41
QOL Medical, LLC2$37

Products named: ENTYVIO, DUPIXENT, RINVOQ, VELSIPITY, XIFAXAN, EOHILIA, REZDIFFRA, XELJANZ.

Industry payments across MO — which companies pay providers there.